Arrow
Arrow
Liv Doctors
Arrow
Prof. MD. Meral Günaldı
Prof. Dr. Meral Günaldı
Prof. MD.

Meral Günaldı

Liv Hospital Ulus
Medical Oncology
Areas of Interests
    • Breast cancer
    • Ovarian cancer
    • Uterine cancer
    • Cervical tumor
    • Lung cancer
    • Colorectal cancer
    • Pancreatic cancer
    • Glioblastoma multiforme
    • Brain tumors
Resume
Publications
Memberships
Awards
Courses Attended
Education:

  • M.D., Faculty of Medicine, Karadeniz Technical University (1994–2001)
  • Residency in Internal Medicine, Okmeydanı Training and Research Hospital (2004–2009)
  • Fellowship in Medical Oncology, Çukurova University, Faculty of Medicine (2009–2013)
  • Associate Professorship in Internal Medicine, Acıbadem University (2016)
  • Professorship, Istanbul Aydın University (2022)

Experience:

  • 2001–2002: Bartın Göçgün Demirci Village, Kozcağız Central Health Center (General Practitioner)
  • 2002–2003: Istanbul University, Istanbul Faculty of Medicine, Department of Neurology (Resident)
  • 2004–2009: Okmeydanı Training and Research Hospital, Department of Internal Medicine (Resident)
  • 2009–2013: Çukurova University, Faculty of Medicine, Department of Medical Oncology (Fellow)
  • 2013–2016: Istanbul Bakırköy Dr. Sadi Konuk Training and Research Hospital (Specialist in Medical Oncology)
  • 2016–2018: Neolife Medical Center (Associate Professor)
  • 2017–2023: Istanbul Aydın University, Faculty of Medicine, Florya Medical Park Hospital (Associate Professor / Professor)
  • 2023–2025: Medicana Ataköy Hospital (Professor, Medical Oncologist)
  • 2025–present: Liv Hospital Ulus

Articles Published in International Peer-Reviewed Journals:
  • Günaldi, M., Helvaci, A., Yildirim, N. D., Kiskaç, M., & Küçükkaya, R. D. (2009). Acute myocardial infarction in a patient with hemophilia A and factor V Leiden mutation. Cardiology Journal, 16(5), 458–461.
  • Duman, B. B., Kara, I. O., Günaldi, M., & Erçolak, V. (2011). Primary cutaneous small-cell carcinoma: A case report. Medical Oncology, 28(Suppl 1), S634–S635.
  • Duman, B. B., Kara, I. O., Günaldi, M., & Ercolak, V. (2011). Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature. Archives of Gynecology and Obstetrics, 283(6), 1363–1368.
  • Gunaldi, M., Helvaci, A., Demirel Yildirim, N., Aydin, D., & Kara, N. (2011). Multiple myeloma with serous membrane involvement and increased CA-125 and CA 15-3. Journal of BUON, 16(4), 778.
  • Günaldi, M., Oguz Kara, I., Duman, B. B., & Gumurdulu, D. (2012). Primary intrapulmonary thymoma associated with myasthenia gravis. General Thoracic and Cardiovascular Surgery, 60(9), 610–613.
  • Duman, B. B., Paydas, S., Tetiker, T., Gunaldı, M., Afsar, C. U., Erçolak, V., Haksöyler, V., & Dilli, M. Ş. (2012). Capecitabine-induced hypertriglyceridemia and hyperglycemia: Two cases. Pharmacology, 90(3–4), 212–215.
  • Duman, B. B., Afşar, Ç. U., Günaldi, M., Sahin, B., Kara, I. O., Erkisi, M., & Erçolak, V. (2012). Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients. Asian Pacific Journal of Cancer Prevention, 13(8), 4119–4123.
  • Duman, B. B., Gunaldi, M., Ercolak, V., Afsar, C. U., Sahin, B., Erkisi, I. M., Kara, O., Paydas, S., Gönlüsen, G., & Sertdemir, Y. (2012). Retrospective analysis of 498 primary soft tissue sarcomas in a single Turkish centre. Asian Pacific Journal of Cancer Prevention, 13(8), 4125–4128.
  • Gunaldi, M., Kara, I. O., Duman, B. B., & Ercolak, V. (2012). Primary intracerebral myeloid sarcoma. Onkologie, 35(11), 694–697.
  • Günaldi, M., Paydas, S., & Afsar, C. U., & Doran, F. (2013). Coexistence of tuberous sclerosis complex and malignant melanoma. Singapore Medical Journal, 54(11), e233–e235.
  • Günaldı, M., Paydaş, S., Usul Afşar, C., Bozkurt Duman, B., & Erçolak, V., Haksöyler, V. (2013). Carbamazepine and multiple myeloma: Possible interaction. Turkish Journal of Haematology, 30(1), 83–84.
  • Usul Afşar, C., Paydaş, S., Günaldı, M., Bozkurt Duman, B., Erçolak, V., Zorludemir, S., & Açıkalın, A. (2013). Sweet syndrome in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma: Curious lymphocyte/neutrophil fluctuations. Turkish Journal of Haematology, 30(4), 413–415.
  • Erçolak, V., Kara, O., Günaldı, M., Usul Afşar, C., Bozkurt Duman, B., Açıkalın, A., Ergin, M., & Erdoğan, S. (2014). Bilateral primary adrenal non-Hodgkin lymphoma. Turkish Journal of Haematology, 31(2), 205–206.
  • Gunaldi, M., Kara, I. O., Duman, B. B., Afsar, C. U., Ergin, M., & Avci, A. (2014). A new approach to the treatment of metastatic paraganglioma: Sorafenib. Cancer Research and Treatment, 46(4), 411–414.
  • Sözütek, D., Yanık, S., Akkoca, A. N., Sözütek, A., Ozdemir, Z. T., Avşar, C. U., Günaldı, M., Sahin, B., & Doron, F. (2014). Diagnostic and prognostic roles of DOG1 and Ki-67, in GIST patients with localized or advanced/metastatic disease. International Journal of Clinical and Experimental Medicine, 7(7), 1914–1922.
  • Ercolak, V., Paydas, S., Ergin, M., Ates, B. T., Duman, B. B., Gunaldi, M., & Afsar, C. U. (2014). Abdominal actinomycosis with multiple myeloma: A case report. Oncology Letters, 8(4), 1876–1878.
  • Paydaş, S., Ozdoğu, H., Günaldı, M., Haksöyler, V., Açıkalın, A., & Ergin, M. (2014). Extramedullary myeloid tumor involving the pancreas: A case report and review of the literature. Turkish Journal of Haematology, 31(3), 295–300.
  • Günaldı, M., Erkisi, M., Afşar, C. U., Erçolak, V., Paydas, S., Kara, I. O., Sahin, B., Gulec, U. K., & Secilmis, A. (2014). Evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisms in Turkish breast cancer patients receiving tamoxifen treatment. Pharmacology, 94(3–4), 183–189.
  • Afsar, C. U., Gunaldi, M., Kum, P., Sahin, B., Erkisi, M., Kara, I. O., Paydas, S., Duman, B. B., Ercolak, V., Karaca, F., Uyeturk, U., & Guner, S. I. (2014). Pancreatic carcinoma, thrombosis and mean platelet volume: Single center experience from the southeast region of Turkey. Asian Pacific Journal of Cancer Prevention, 15(21), 9143–9146.
  • Gunaldi, M., Duman, B. B., Afsar, C. U., Paydas, S., Erkisi, M., Kara, I. O., & Sahin, B. (2016). Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study. Journal of Oncology Pharmacy Practice, 22(2), 242–247.
  • Karaca, F., Afsar, C. U., Gunaldi, M., Erkurt, E., Ercolak, V., Sertdemir, Y., & Paydas, S. (2015). Alterations of ghrelin with weights and correlation among ghrelin, cytokine and survival in patients receiving chemoradiotherapy for gastrointestinal cancers. International Journal of Clinical and Experimental Medicine, 8(1), 876–882.
  • Okuturlar, Y., Gunaldi, M., Tiken, E. E., Oztosun, B., Inan, Y. O., Ercan, T., Tuna, S., Kaya, A. O., Harmankaya, O., & Kumbasar, A. (2015). Utility of peripheral blood parameters in predicting breast cancer risk. Asian Pacific Journal of Cancer Prevention, 16(6), 2409–2412.
  • Gunaldi, M., Afsar, C. U., Okuturlar, Y., Gedikbasi, A., Kocoglu, H., Kural, A., Akarsu, C., Gunduz, U., & Tiken, E. E. (2015). Elevated serum levels of heat shock protein 70 are associated with breast cancer. Tohoku Journal of Experimental Medicine, 236(2), 97–102.
  • Ercolak, V., Paydas, S., Bagir, E., Ergin, M., Seydaoglu, G., Celik, H., Yavu, B., Tanriverdi, K., Gunaldi, M., Afsar, C. U., & Duman, B. B. (2015). PRAME expression and its clinical relevance in Hodgkin's lymphoma. Acta Haematologica, 134(4), 199–207.
  • Gunaldi, M., Goksu, S., Erdem, D., Gunduz, S., Okuturlar, Y., Tiken, E., Kahraman, S., Inan, Y. O., Genc, T. B., & Yildirim, M. (2015). Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: A multicenter study. International Journal of Clinical and Experimental Medicine, 8(4), 5937–5942.
  • Günaldı, M., Afsar, C. U., Duman, B. B., Kara, I. O., Tatli, U., & Sahin, B. (2015). Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws. Oncology Letters, 10(1), 439–442.
  • Karabulut, M., Gunaldi, M., Alis, H., Afsar, C. U., Karabulut, S., Serilmez, M., Akarsu, C., Seyit, H., & Aykan, N. F. (2016). Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma. Clinical and Translational Oncology, 18(2), 160–171.
  • Okuturlar, Y., Gedikbasi, A., Akalin, N., Gunaldi, M., Yilmaz, D., Mert, M., Harmankaya, O., Soylu, A., Karakaya, P., & Kumbasar, A. (2016). Serum paraoxonase 1 activity in patients with iron deficiency anemia. Archives of Medical Science, 12(4), 697–703.
  • Okuturlar, Y., Ozkalemkas, F., Ener, B., Serin, S. O., Kazak, E., Ozcelik, T., Ozkocaman, V., Ozkan, H. A., Akalin, H., Gunaldi, M., & Ali, R. (2015). Serum galactomannan levels in the diagnosis of invasive aspergillosis. Korean Journal of Internal Medicine, 30(6), 899–905.
  • Ercolak, V., Sahin, B., Gunaldi, M., Duman, B. B., & Afsar, C. U. (2015). Efficacy of paclitaxel in the treatment of Kaposi sarcoma. European Review for Medical and Pharmacological Sciences, 19(21), 4095–4100.
  • Usul Afsar, C., Sahin, B., Gunaldi, M., Kılıc Bagir, E., Gumurdulu, D., Burgut, R., Erkisi, M., Kara, I. O., Paydas, S., Karaca, F., & Ercolak, V. (2015). Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in squamous cell carcinoma of the lung. International Journal of Clinical and Experimental Pathology, 8(9), 9760–9771.
  • Gunaldi, M., Okuturlar, Y., Gedikbasi, A., Akarsu, C., Karabulut, M., & Kural, A. (2015). Diagnostic importance of S100A9 and S100A12 in breast cancer. Biomedicine & Pharmacotherapy, 76, 52–56.
  • Karabulut, M., Alis, H., Bas, K., Karabulut, S., Afsar, C. U., Oguz, H., Gunaldi, M., Akarsu, C., Kones, O., & Aykan, N. F. (2015). Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer. Molecular and Clinical Oncology, 3(6), 1255–1267.
  • Gunaldi, M., Kocoglu, H., Okuturlar, Y., Gedikbasi, A., Karabulut, M., & Hursitoglu, M. (2015). Heat shock protein 70 is a useful marker for predicting colorectal cancer. Journal of BUON, 20(6), 1464–1470.
  • Afsar, C. U., Gunaldı, M., Okuturlar, Y., Gedikbası, A., Tiken, E. E., Kahraman, S., Karaca, F., Ercolak, V., & Karabulut, M. (2015). Paraoxonase-1 and arylesterase activities in patients with colorectal cancer. International Journal of Clinical and Experimental Medicine, 8(11), 21599–21604.
  • Ekmen, N., Helvaci, A., Gunaldi, M., Sasani, H., & Yildirmak, S. T. (2016). Leptin as an important link between obesity and cardiovascular risk factors in men with acute myocardial infarction. Indian Heart Journal, 68(2), 132–137.
  • Kocoglu, H., Dogan, H., Oguz, B., Ocak Serin, S., Okuturlar, Y., Gunaldi, M., Erismis, B., Ozdemir, B., Tural, D., Hursitoglu, M., Harmankaya, O., & Kumbasar, A. (2016). Comparison of survival rates, tumor stages, and localization in obese and nonobese patients with gastric cancer. Gastroenterology Research and Practice, 2016, 9382750.
  • Gündüz, U. R., Gunaldi, M., Isiksacan, N., Gündüz, S., Okuturlar, Y., & Kocoglu, H. (2016). A new marker for breast cancer diagnosis, human epididymis protein 4: A preliminary study. Molecular and Clinical Oncology, 5(2), 355–360.
  • Tanriverdi, O., Menekse, S., Teker, F., Oktay, E., Nur Pilanc, K., Gunaldi, M., Kocar, M., Kacan, T., Bahceci, A., Avci, N., Akman, T., Cokmert, S., Yesil-Cinkir, H., & Teoman Yanmaz, M. (2016). The mean platelet volume may predict the development of isolated bone metastases in patients with breast cancer: A retrospective study of the Young Researchers Committee of the Turkish Oncology Group (TOG). Journal of BUON, 21(4), 840–850.
  • Gunaldi, M., Kose, F., Demirci, N. S., Gunduz, S., Ozdemir, N., Kocoglu, H., Okuturlar, Y., Sedef, A. M., Erdem, D., Goksu, S. S., Erdem, G. U., & Yildirim, M. (2018). Adding taxane to platin-5-fluorouracil combination does not improve survival rate in patients ≥ 65 years of age with advanced gastric cancer: A retrospective multicenter study. Journal of BUON, 23(2), 416–421.
  • Gunaldi, M., Isiksacan, N., Kocoglu, H., Okuturlar, Y., Gunaldi, O., Topcu, T. O., & Karabulut, M. (2018). The value of serum survivin level in early diagnosis of cancer. Journal of Cancer Research and Therapeutics, 14(3), 570–573.
  • Topcu, T. O., Ozdemir, F., Kavgaci, H., Gunaldi, M., Kocoglu, H., Imamoglu, G. I., Mentese, A., Yaman, S. O., Orem, A., & Aydin, F. (2018). The clinical importance of serum urokinase plasminogen activator receptor and carbonic anhydrase IX levels and the effect of anthracycline-based adjuvant chemotherapy on these biomarkers in breast cancer. Journal of Cancer Research and Therapeutics, 14(3), 608–613.
  • Okuturlar, Y., Gunaldi, M., Kocoglu, H., Hursitoglu, M., Gedikbasi, A., Acarer, D., Harmankaya, O., & Kumbasar, A. (2018). Serum paraoxonase and arylesterase can be useful markers to predict neoadjuvant chemotherapy requirement in patients with breast cancer. Journal of Cancer Research and Therapeutics, 14(Suppl), S362–S367.
  • Şişman, H., Özgen, R., Baysal, D., Sarıakçalı, N., Öztürk, S., Kum, P., Gürel, D., Kanarığ, D., Aslaner, E., Akıl, Y., & Günaldı, M. (2014). Measurement of the knowledge level about breast self-exam among the female employees of a university hospital, Turkey. Asia-Pacific Journal of Oncology Nursing, 1(1), 40–45.
  • Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The lifetime cost-of-disease (CoD) of metastatic colorectal cancer (mCRC) in Turkey: An expert panel approach for estimation of costs. Value in Health, 18(7), A448.
  • Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The cost-of-disease of metastatic/inoperable gastrointestinal stromal tumors in Turkey: An expert panel approach for estimation of costs. Value in Health, 18(7), A449.
  • Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The cost-effectiveness of regorafenib in the treatment of metastatic/inoperable gastrointestinal stromal tumors in Turkey. Value in Health, 18(7), A455.
  • Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The cost-effectiveness of regorafenib in the treatment of patients with metastatic colorectal cancer (mCRC) who have progressed after standard therapies in Turkey. Value in Health, 18(7), A458.
  • Gunaldi, M., Erdem, D., Goksu, S., Gunduz, S., Okuturlar, Y., Tiken, E., Aksoy, H., & Yildirim, M. (2016). Platelet distribution width as a predictor of metastasis in gastric cancer patients. Journal of Gastrointestinal Cancer.
  • Demir, A., Molinas Mandel, N., Paydas, S., Demir, G., Er, O., Turhal, N. S., Bavbek, S., Eralp, Y., Saip, P. M., Güler, E. N., Aydıner, A., Uluç, B. O., Kılıçkap, S., Üskent, N., Karadurmuş, N., Kaplan, M. A., Yanmaz, M. T., Demir, H., Alan, O., Korkmaz, T., Olgun, P., Uysal, Ö. S., Altundağ, K., Gündüz, Ş., Günaldı, M., Sarı, M., Beypınar, İ., & Başaran, G. (2020). [Article title unavailable]. Balkan Medical Journal, 37(2), 104–107.
Presentations Published in International Conference Proceedings:
  • Gunaldi, M., Kara, I. O., Afsar, C. U., & Duman, B. B. (2012, June 1–5). Sorafenib in the treatment of metastatic paraganglioma: A case report [Poster presentation]. 2012 ASCO Annual Meeting, Chicago, IL, United States.
  • Duman, B. B., Gunaldi, M., Tasdogan, B. E., Afsar, C. U., Paydas, S., & Gumurdulu, Y. (2012, May–June). Nonalcoholic fatty liver disease after adjuvant therapy in nonmetastatic breast cancer [Poster presentation]. ASCO Annual Meeting, Chicago, IL, United States.
  • Gunaldi, M., Sahin, B., & Tatlı, U. (2011). Osteonecrosis of the jaw in cancer patients treated with bisphosphonates [Poster presentation]. Mediterranean Multidisciplinary Oncology Forum Congress.
  • Tiken, E. E., Günaldı, M., Okuturlar, Y., & Tuna, S. (2014, September 30–October 2). The evaluation of synchronous bilateral breast cancer patients [Poster presentation]. International Breast Cancer Conference, Istanbul, Turkey.
  • Okuturlar, Y., Günaldı, M., Tiken, E. E., Tuna, S., Oztosun, B., Inan, Y., Ercan, T., Harmankaya, O., & Kumbasar, B. (2014, September 30–October 2). Evaluation of body mass index in breast cancer patients [Poster presentation]. International Breast Cancer Conference, Istanbul, Turkey.
  • Günaldı, M., Tiken, E. E., Okuturlar, Y., Tuna, S., & Kapan, S. (2014, September 30–October 2). Neoadjuvant chemotherapy in breast cancer patients: Single centre experience [Poster presentation]. International Breast Cancer Conference, Istanbul, Turkey.
  • Gunaldi, M., Erkisi, M., Afsar, C. U., Ercolak, V., Paydas, S., Kara, I. O., Sahin, B., Gulec, U., & Secilmis, A. (2014). The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisms in Turkish breast cancer patients receiving tamoxifen treatment [Poster presentation]. ASCO Annual Meeting, Chicago, IL, United States.
  • Afsar, C. U., Sahin, B., Gumurdulu, D., Kılıc Bagir, E., Burgut, R., Erkisi, M., Kara, I. O., Gunaldi, M., & Ercolak, V. (2014, September 26–30). The evaluation of fibroblast growth factor receptor 1 (FGFR1), fibroblast growth factor 2 (FGF2), phosphatidylinositol 3 phosphate kinase (IP3K) expression and their clinical, prognostic significance in early and advanced stage of squamous cell carcinoma of the lung [Poster presentation]. 39th ESMO Congress, Madrid, Spain.
  • Helvaci, A., Çorbacıoğlu, E., & Günaldı, M. (2010, April 15–18). Acute coronary syndrome and its relation with diabetes mellitus and antidiabetic drug [Poster presentation]. 59th ESCVS International Congress in conjunction with the 6th Congress of Update in Cardiology and Cardiovascular Surgery, Cesme, Izmir, Turkey.
  • Okuturlar, Y., Gedikbasi, A., Akalin, N., Gunaldi, M., Yilmaz, D., Karakaya, P., Mert, M., & Harmankaya, O. (2014, June 22–26). Effects of iron therapy on paraoxonase and arylesterase activities in patients with iron deficiency anemia [Poster presentation]. IFCC WorldLab Istanbul 2014, 22nd International Congress of Clinical Chemistry and Laboratory Medicine, Istanbul, Turkey.
  • Afsar, C. U., Gunaldi, M., Okuturlar, Y., Gedikbaşı, A., & Kural, A. (2014). Paraoxonase and arylesterase activities in patients with colorectal cancer [Poster presentation]. Advances in Predictive & Personalized Medicine.
  • Gunaldi, M., Afsar, C. U., Okuturlar, Y., Gedikbaşı, A., Kural, A., & Tiken, E. E. (2014). Can heat shock protein 70 be a target therapy in breast cancer? [Poster presentation]. Advances in Predictive & Personalized Medicine.
  • Okuturlar, Y., Gunaldi, M., Gedikbaşı, A., Kural, A., & Acarer, D. (2014). Breast cancer and paraoxonase activity [Poster presentation]. Advances in Predictive & Personalized Medicine.
  • Isıksacan, N., Koşer, M., Gunaldi, M., & Ördekçi, S. (2014). C-reactive protein (CRP) measurement using point of care (POC) devices [Poster presentation]. Advances in Predictive & Personalized Medicine.
  • Oztosun, B., Okuturlar, Y., Gunaldi, M., Soyluk, S., Biricik, Ö., Mert, M., Sayilan, S., Orman, M., & Kaptanoğulları, Ö. (2014). An aggressive malignant insulinoma: A case report [Poster presentation]. European Congress of Endocrinology.
  • Abbasoğlu, D., Gunaldi, M., Sivas, H., Yakıcıer, M. C., & Hızel, H. C. (2014). The factors affecting UGT1A1 enzyme activity of irinotecan drug response in Turkish population [Poster presentation]. 7th Santorini Conference on Systems Personalized Health and Therapy.
  • Gunaldi, M., & Helvaci, A. (2010, April 15–18). Alteration in serum levels of selenium and glutathione peroxidase in acute myocardial infarction [Poster presentation]. 59th ESCVS International Congress in conjunction with the 6th Congress of Update in Cardiology and Cardiovascular Surgery, Cesme, Izmir, Turkey.
  • Günaldı, M., Tiken, E. E., Okuturlar, Y., Tuna, S., & Kapan, S. (2014). Neoadjuvant chemotherapy in breast cancer patients: Single centre experience [Poster presentation]. International Breast Cancer Conference, Istanbul, Turkey.
  • Okuturlar, Y., Tiken, E. E., Tuna, S., Oztosun, B., Inan, Y., Ercan, T., Harmankaya, O., & Kumbasar, B. (2014). Evaluation of body mass index in breast cancer patients [Poster presentation]. International Breast Cancer Conference, Istanbul, Turkey.
  • Günaldı, M., Gürgenyataği, D., Göksu, S., Gülenay, Ş., Yildirim, M., Tiken, E., Okuturlar, Y., & Kahraman, S. (2014). A factor that predicts occurrence of metastasis on stomach cancer patients: PDW [Poster presentation]. 4th International Gastrointestinal Cancer Conference.
  • Okuturlar, Y., Günaldı, M., Gedikbaşı, A., Kural, A., & Acarer, D. (2015). Breast cancer and paraoxonase activity [Poster presentation]. Cancer International Symposium on Advances in Predictive & Personalized Medicine.
  • Gunaldi, M., Goksu, S., Gunduz, S., Okuturlar, Y., Tiken, E., Kahraman, S., & Isıksacan, N. (2015, September 6–9). Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: A multicenter study [Poster presentation]. 4th European Congress of Immunology, Vienna, Austria.
  • Gunaldi, M., Okuturlar, Y., Kural, A., Akarsu, C., Karabulut, M., & Gedikbasi, A. (2015, September 6–9). Clinical importance of S100A9 and S100A12 in breast cancer [Poster presentation]. 4th European Congress of Immunology, Vienna, Austria.
  • Gunaldi, M., Isıksacan, N., Okuturlar, Y., Kocoglu, H., & Gunaldi, O. (2015, September 6–9). Clinical significance of serum survivin in cancer patients [Poster presentation]. 4th European Congress of Immunology, Vienna, Austria.
Published National/International Books or Boom Chapters

  • Yıldırım, Y., Günaldı, M., & Karaarslan, S. (2013). Classification, usage, and toxicity in chemotherapeutic and molecular targeted therapy. In H. Onat (Ed.), Cancer Chemotherapy Handbook. Çukurova Nobel Kitabevi.
  • Günaldı, Ö., & Günaldı, M. (2014). Ommaya reservoir. In Shunt Surgery in Neurosurgery. Selen Yayıncılık.
Published National/International Books
  • Günaldı, M. (2022, February). Current approaches in gastrointestinal system cancers - Treatment of metastatic well-differentiated gastrointestinal and pancreatic neuroendocrine tumors.
  • Günaldı, Ö., & Günaldı, M. (2014). Ommaya reservoir. In Shunt Surgery in Neurosurgery. Selen Yayıncılık.
  • Yıldırım, Y., Günaldı, M., & Karaarslan, S. (2013). Classification, usage, and toxicity in chemotherapeutic and molecular targeted therapy. In H. Onat (Ed.), Cancer Chemotherapy Handbook. Çukurova Nobel Kitabevi.
Published in National Peer-Reviewed Journals
  • Günaldi, M., Duman, B. B., Erçolak, V., Afşar, Ç. U., Kara, İ. O., & Şahin, B. (2012). Three different sorafenib-related skin toxicities: A case report. Turkish Journal of Dermatology.
  • Yılmaz, G., Adaş, M., Helvacı, A., Altıntaş, N., & Günaldi, M. (2013). Evaluation of respiratory functions in subclinical and clinical hypothyroidism. Journal of Turgut Ozal Medical Center.
  • Tiken, E. E., Günaldi, M., Okuturlar, Y., & Sever, N. (2014). Gastric metastasis of invasive lobular breast cancer: A case report. Turkish Journal of Oncology, 29(4), 157–161.
  • Günaldi, M., Duman, B. B., Afşar, Ç. U., Günaldı, Ö., & Şahin, B. (2014). Langerhans cell histiocytosis located in the temporal bone: A case report. Göztepe Medical Journal.
  • Karaca, F., Erçolak, V., Afşar, Ç. U., & Günaldi, M. (2015). Diffuse large B-cell lymphoma of the breast. Çukurova Medical Journal.
  • Günaldi, M., & Köksal Erkiş, M. (2014). Chemotherapy in glioblastoma multiforme. Klinik Tıp Bilimleri.
  • Gözkaman, A., Okuturlar, Y., Kanat, Ö., Günaldi, M., Serin, S. O., Saydaroğlu, Ö., Kumbasar, A., & Evrensel, T. (2015). C-Kit (CD117) expression in patients with small cell lung cancer. Haseki Tıp Bülteni, 53, 67–71.
  • Okuturlar, Y., Günaldi, M., Tiken, E. E., Tuna, S., Öztosun, B., Özdeminan, Y., Ercan, T., Harmankaya, Ö., & Kumbasar, A. (2015). The effect of overweight and obesity on breast cancer subtypes. Journal of Clinical and Analytical Medicine.
  • Tiken, E. E., Günaldi, M., Okuturlar, Y., & Tuna, S. (2015). Evaluation of patients with synchronous bilateral breast cancer. Istanbul Medical Journal.
  • Okuturlar, Y., Mert, M., Soyluk, Ö., Enki, S., Sayilan, S., Gönenç, M., Günaldi, M., Kumbasar, A., Aliş, H., & Harmankaya, Ö. (2015). A rare cause of hypoglycemia in old age: Insulinoma. Bakırköy Medical Journal.
  • Günaldi, M., Duman, B. B., Erçolak, V., Afşar, Ç. U., Paydaş, S., Köksal Erkiş, M., Kara, İ. O., Şahin, B., & Gönlüsen, G. (2014). Retrospective evaluation of osteosarcomas. Journal of Clinical and Analytical Medicine.
  • Günaldi, M. (2014). Breast cancer risk factors. Klinik Tıp Aile Hekimliği Dergisi.
  • Özkara, İ. Ö., & Günaldi, M. (2014). Gastric cancer: Prevention, risk factors and prognosis. Klinik Tıp Aile Hekimliği Dergisi.
Presentations Published in National Conference Proceedings:

  • Günaldı, M., Duman, B. B., Erçolak, V., Afşar, Ç. U., Paydaş, S., Kara, İ. O., Erkişi, M., & Şahin, B. (2012, March 21–25). Investigation of the contribution of epirubicin and doxorubicin to trastuzumab-related cardiotoxicity [Poster presentation]. 4th Medical Oncology Congress, Antalya, Turkey.
  • Günaldı, M., Paydaş, S., Afşar, Ç. U., Erçolak, V., Duman, B. B., & Doran, F. (2012, March 21–25). Coexistence of tuberous sclerosis and malignant melanoma [Poster presentation]. 4th Medical Oncology Congress, Antalya, Turkey.
  • Günaldı, M. (2012, March 21–25). Primary appendiceal adenocarcinoma diagnosed with bilateral ovarian metastasis [Poster presentation]. 4th Medical Oncology Congress, Antalya, Turkey.
  • Günaldı, M., Erkişi, M., Afşar, Ç. U., Duman, B. B., & Erçolak, V. (2012, March 21–25). Richter syndrome [Poster presentation]. 4th Medical Oncology Congress, Antalya, Turkey.
  • Duman, B. B., Afşar, Ç. U., Günaldı, M., Erkişi, M., Kara, İ. O., Şahin, B., & Kum, P. (2013, April 19–23). Our experience with adjuvant/neoadjuvant chemotherapy in breast cancer patients [Poster presentation]. 20th National Cancer Congress, Antalya, Turkey.
  • Günaldı, M., Kara, İ. O., Afşar, Ç. U., Erçolak, V., & Duman, B. B. (2012, March 21–25). Malignant mesenchymal tumor accompanying acromegaly [Poster presentation]. 4th Medical Oncology Congress, Antalya, Turkey.
  • Erçolak, V., Paydaş, S., Şeydaoğlu, G., Günaldı, M., Afşar, Ç. U., & Duman, B. B. (2013). Retrospective evaluation of Hodgkin lymphoma cases [Poster presentation]. 5th Medical Oncology Congress, Antalya, Turkey.
  • Gunaldi, M., Okuturlar, Y., & Tiken, E. E. (2014, September). Molecular subgroup evaluation in geriatric breast cancer patients [Poster presentation]. 1st Geriatric Oncology Congress, Antalya, Turkey.
  • Günaldı, M., Erkişi, M., Afşar, Ç. U., Duman, B. B., & Erçolak, V. (2012, March 21–25). Alpha-2 globulin peak in a patient with lung adenocarcinoma [Poster presentation]. 4th Medical Oncology Congress, Antalya, Turkey.
  • Duman, B. B., Şahin, B., Erkişi, M., Paydaş, S., Kara, İ. O., Afşar, Ç. U., Günaldı, M., Erçolak, V., & Kum, P. (2012, March 21–25). Effect of cytoreductive nephrectomy on survival in metastatic renal cell carcinoma [Poster presentation]. 4th Medical Oncology Congress, Antalya, Turkey.
  • Günaldı, M., Şahin, B., Duman, B. B., Erçolak, V., & Afşar, Ç. U. (2012, March 21–25). Is bevacizumab a risk factor for jaw osteonecrosis? [Poster presentation]. 4th Medical Oncology Congress, Antalya, Turkey.
  • Turkish Society of Medical Oncology (TTOD) – Board Member (2020–2022)
  • Interdisciplinary Oncology Association (IDOD)
  • Turkish Neuro-Oncology Society
  • European Society for Medical Oncology (ESMO)

  • Associate Professor Dr. Metin Karan Article Award (2013)
  • Medical Oncology Society Presentation Award (2012)
  • Poster Presentation Third Prize

  • A to Z Biological Therapies Course (2023)
  • Turkish Society of Medical Oncology Courses (2020–2022)
  • Palliative Care Congress (2018)
  • Uludağ Medical Oncology Symposium (2018)

Ask our Experts!
You can contact with our experts for your questions!